Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Estrogens | 6 | 2020 | 252 | 2.84 | Why? |
| Estrogen Replacement Therapy | 4 | 2020 | 50 | 2.17 | Why? |
| Sex Characteristics | 9 | 2021 | 1120 | 2.12 | Why? |
| Diabetes Mellitus, Type 2 | 13 | 2020 | 6166 | 1.47 | Why? |
| Insulin-Secreting Cells | 5 | 2018 | 273 | 1.47 | Why? |
| Estradiol | 3 | 2020 | 250 | 1.44 | Why? |
| Islets of Langerhans | 3 | 2017 | 138 | 1.37 | Why? |
| Menopause | 2 | 2017 | 136 | 1.18 | Why? |
| Receptors, Androgen | 4 | 2021 | 212 | 1.06 | Why? |
| Selective Estrogen Receptor Modulators | 2 | 2020 | 65 | 0.86 | Why? |
| Energy Metabolism | 4 | 2017 | 451 | 0.84 | Why? |
| Insulin | 5 | 2018 | 1316 | 0.83 | Why? |
| Progesterone | 1 | 2020 | 106 | 0.80 | Why? |
| Immunomodulation | 2 | 2020 | 1472 | 0.80 | Why? |
| Sex Factors | 11 | 2021 | 11014 | 0.78 | Why? |
| Homeostasis | 3 | 2017 | 582 | 0.76 | Why? |
| Diabetes Mellitus, Type 1 | 3 | 2017 | 1969 | 0.71 | Why? |
| Cytoprotection | 1 | 2017 | 44 | 0.71 | Why? |
| Pancreas | 1 | 2021 | 398 | 0.69 | Why? |
| Blood Glucose | 6 | 2017 | 3642 | 0.68 | Why? |
| Aging | 3 | 2020 | 3581 | 0.67 | Why? |
| Androgen Antagonists | 1 | 2021 | 404 | 0.67 | Why? |
| Metabolism | 1 | 2017 | 74 | 0.65 | Why? |
| Incretins | 1 | 2017 | 61 | 0.65 | Why? |
| Endocrine System Diseases | 1 | 2020 | 282 | 0.64 | Why? |
| Glucose Intolerance | 1 | 2017 | 115 | 0.62 | Why? |
| Receptors, Estrogen | 1 | 2017 | 171 | 0.61 | Why? |
| Androgens | 1 | 2018 | 267 | 0.58 | Why? |
| Postmenopause | 1 | 2017 | 160 | 0.58 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 2 | 2017 | 436 | 0.58 | Why? |
| Insulin Resistance | 2 | 2018 | 669 | 0.56 | Why? |
| Angiotensin II | 1 | 2020 | 601 | 0.55 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.49 | Why? |
| Metabolic Diseases | 1 | 2018 | 505 | 0.48 | Why? |
| Metabolic Syndrome | 1 | 2020 | 810 | 0.47 | Why? |
| Neurons | 1 | 2018 | 864 | 0.46 | Why? |
| Precision Medicine | 2 | 2020 | 1477 | 0.43 | Why? |
| Obesity | 4 | 2020 | 7388 | 0.42 | Why? |
| Models, Biological | 2 | 2017 | 4907 | 0.39 | Why? |
| Diabetes Mellitus | 3 | 2021 | 8207 | 0.38 | Why? |
| Diabetes Complications | 2 | 2021 | 2358 | 0.37 | Why? |
| Diet, Western | 2 | 2018 | 42 | 0.35 | Why? |
| Health Status | 1 | 2020 | 3259 | 0.32 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.31 | Why? |
| Inflammation | 2 | 2020 | 13255 | 0.31 | Why? |
| Coronary Artery Disease | 1 | 2019 | 2570 | 0.27 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.27 | Why? |
| Mice, Knockout | 3 | 2018 | 1815 | 0.27 | Why? |
| Transcriptome | 1 | 2017 | 3466 | 0.26 | Why? |
| New Orleans | 2 | 2021 | 166 | 0.25 | Why? |
| Mice | 8 | 2021 | 21357 | 0.24 | Why? |
| Animals | 14 | 2021 | 78931 | 0.24 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.23 | Why? |
| Progestins | 1 | 2020 | 43 | 0.22 | Why? |
| Mitochondria | 2 | 2018 | 857 | 0.21 | Why? |
| Serine Endopeptidases | 3 | 2021 | 4606 | 0.21 | Why? |
| Contraceptives, Oral, Hormonal | 1 | 2020 | 42 | 0.21 | Why? |
| Pituitary Diseases | 1 | 2020 | 38 | 0.21 | Why? |
| Furosemide | 1 | 2021 | 99 | 0.21 | Why? |
| Glucagon-Like Peptide 1 | 2 | 2017 | 83 | 0.21 | Why? |
| Gene Expression | 2 | 2021 | 3332 | 0.20 | Why? |
| Hypoglycemic Agents | 3 | 2017 | 2165 | 0.20 | Why? |
| HSP27 Heat-Shock Proteins | 1 | 2018 | 3 | 0.19 | Why? |
| Glucagon-Like Peptide-1 Receptor | 2 | 2017 | 138 | 0.19 | Why? |
| Hypogonadism | 1 | 2020 | 196 | 0.19 | Why? |
| Streptozocin | 1 | 2018 | 29 | 0.19 | Why? |
| Dihydrotestosterone | 1 | 2018 | 39 | 0.19 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.19 | Why? |
| Hyperinsulinism | 1 | 2018 | 27 | 0.19 | Why? |
| Sulfonylurea Receptors | 1 | 2017 | 3 | 0.18 | Why? |
| Hypothalamus | 1 | 2018 | 58 | 0.18 | Why? |
| Gluconeogenesis | 1 | 2017 | 41 | 0.18 | Why? |
| Transcription Factor 7-Like 2 Protein | 1 | 2017 | 6 | 0.18 | Why? |
| Female | 20 | 2021 | 380317 | 0.18 | Why? |
| Estrogen Receptor alpha | 1 | 2018 | 40 | 0.18 | Why? |
| Linagliptin | 1 | 2017 | 22 | 0.18 | Why? |
| Crosses, Genetic | 1 | 2017 | 13 | 0.18 | Why? |
| Potassium Channels, Inwardly Rectifying | 1 | 2017 | 29 | 0.17 | Why? |
| Fibrosis | 1 | 2021 | 800 | 0.17 | Why? |
| Adiposity | 1 | 2020 | 329 | 0.17 | Why? |
| Mice, Inbred NOD | 1 | 2017 | 134 | 0.17 | Why? |
| Prostatic Neoplasms | 2 | 2021 | 1637 | 0.17 | Why? |
| Diabetic Angiopathies | 1 | 2019 | 146 | 0.17 | Why? |
| Male | 18 | 2021 | 367725 | 0.17 | Why? |
| AMP-Activated Protein Kinases | 1 | 2017 | 93 | 0.16 | Why? |
| Islets of Langerhans Transplantation | 1 | 2017 | 41 | 0.16 | Why? |
| Sulfonylurea Compounds | 1 | 2017 | 79 | 0.16 | Why? |
| Apoptosis | 2 | 2018 | 2335 | 0.16 | Why? |
| Glucose | 2 | 2018 | 573 | 0.16 | Why? |
| Raloxifene Hydrochloride | 1 | 2017 | 91 | 0.16 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.16 | Why? |
| Thyroid Diseases | 1 | 2020 | 285 | 0.16 | Why? |
| Tamoxifen | 1 | 2017 | 83 | 0.16 | Why? |
| Humans | 30 | 2021 | 930598 | 0.15 | Why? |
| Hormone Replacement Therapy | 1 | 2017 | 146 | 0.15 | Why? |
| Genetic Markers | 1 | 2017 | 318 | 0.15 | Why? |
| Endoplasmic Reticulum Stress | 1 | 2018 | 253 | 0.15 | Why? |
| Blood Pressure | 2 | 2017 | 2198 | 0.15 | Why? |
| Immune Tolerance | 1 | 2020 | 608 | 0.15 | Why? |
| Gene Ontology | 1 | 2017 | 391 | 0.15 | Why? |
| Metabolic Networks and Pathways | 1 | 2017 | 285 | 0.14 | Why? |
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 334 | 0.14 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2017 | 192 | 0.14 | Why? |
| Antineoplastic Agents, Hormonal | 1 | 2017 | 203 | 0.14 | Why? |
| Bone Density Conservation Agents | 1 | 2017 | 209 | 0.14 | Why? |
| Mice, Transgenic | 2 | 2021 | 2739 | 0.13 | Why? |
| Age Factors | 4 | 2020 | 21039 | 0.13 | Why? |
| Receptors, G-Protein-Coupled | 1 | 2017 | 309 | 0.13 | Why? |
| Risk Factors | 7 | 2021 | 71621 | 0.13 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.13 | Why? |
| Preventive Health Services | 1 | 2019 | 501 | 0.13 | Why? |
| Cell Membrane | 1 | 2018 | 743 | 0.13 | Why? |
| Prenatal Exposure Delayed Effects | 1 | 2017 | 319 | 0.12 | Why? |
| Cholesterol, LDL | 1 | 2017 | 499 | 0.12 | Why? |
| Lipid Metabolism | 1 | 2017 | 572 | 0.12 | Why? |
| Rats | 1 | 2020 | 2764 | 0.12 | Why? |
| Organ Specificity | 1 | 2017 | 1070 | 0.12 | Why? |
| Transcription, Genetic | 1 | 2018 | 1326 | 0.12 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1014 | 0.11 | Why? |
| Ligands | 1 | 2017 | 1300 | 0.11 | Why? |
| Macaca mulatta | 1 | 2021 | 3716 | 0.11 | Why? |
| Epigenesis, Genetic | 1 | 2017 | 711 | 0.11 | Why? |
| Protective Factors | 1 | 2017 | 1720 | 0.10 | Why? |
| Mice, Inbred C57BL | 2 | 2018 | 5542 | 0.10 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.10 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.10 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.09 | Why? |
| Indoles | 1 | 2017 | 1243 | 0.09 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.09 | Why? |
| Incidence | 3 | 2021 | 25622 | 0.09 | Why? |
| Sequence Analysis, RNA | 1 | 2017 | 2290 | 0.09 | Why? |
| Immune System | 1 | 2017 | 1479 | 0.09 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.08 | Why? |
| Renin-Angiotensin System | 2 | 2020 | 3661 | 0.08 | Why? |
| Racism | 1 | 2020 | 1462 | 0.08 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.08 | Why? |
| Nutritional Status | 1 | 2017 | 1403 | 0.08 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.08 | Why? |
| Autoantibodies | 1 | 2017 | 2094 | 0.08 | Why? |
| Brain | 2 | 2020 | 5133 | 0.07 | Why? |
| Chronic Disease | 1 | 2020 | 5139 | 0.07 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.07 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.07 | Why? |
| African Americans | 1 | 2020 | 3363 | 0.07 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.07 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.06 | Why? |
| Liver | 1 | 2017 | 4007 | 0.06 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.06 | Why? |
| Mice, Inbred Strains | 1 | 2021 | 136 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2017 | 10649 | 0.05 | Why? |
| Pregnancy | 2 | 2020 | 23879 | 0.05 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.05 | Why? |
| Microtubules | 1 | 2018 | 47 | 0.05 | Why? |
| Transcription Factor CHOP | 1 | 2018 | 29 | 0.05 | Why? |
| Health Status Disparities | 1 | 2017 | 4072 | 0.05 | Why? |
| Imidazoline Receptors | 1 | 2017 | 1 | 0.05 | Why? |
| Glucagon-Secreting Cells | 1 | 2017 | 8 | 0.05 | Why? |
| Tumor Cells, Cultured | 1 | 2018 | 254 | 0.04 | Why? |
| Metalloproteases | 1 | 2018 | 34 | 0.04 | Why? |
| Mice, Mutant Strains | 1 | 2017 | 42 | 0.04 | Why? |
| Glucagon | 1 | 2017 | 52 | 0.04 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.04 | Why? |
| Molecular Chaperones | 1 | 2018 | 124 | 0.04 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.04 | Why? |
| Mitochondrial Proteins | 1 | 2018 | 152 | 0.04 | Why? |
| Exons | 1 | 2017 | 158 | 0.04 | Why? |
| Protein Transport | 1 | 2018 | 487 | 0.04 | Why? |
| Stress, Psychological | 1 | 2020 | 10231 | 0.04 | Why? |
| Animals, Newborn | 1 | 2017 | 350 | 0.04 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Lung | 2 | 2021 | 31049 | 0.04 | Why? |
| Heat-Shock Proteins | 1 | 2018 | 226 | 0.04 | Why? |
| Oxidation-Reduction | 1 | 2017 | 540 | 0.04 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.03 | Why? |
| Colchicine | 1 | 2021 | 730 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Aspirin | 1 | 2021 | 1043 | 0.03 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.03 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.03 | Why? |
| DNA Methylation | 1 | 2017 | 688 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.03 | Why? |
| Mutation, Missense | 1 | 2017 | 863 | 0.03 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.03 | Why? |
| Body Weight | 1 | 2017 | 1074 | 0.03 | Why? |
| Endothelial Cells | 1 | 2021 | 2048 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2017 | 1887 | 0.02 | Why? |
| Epithelial Cells | 1 | 2021 | 3508 | 0.02 | Why? |
| Aged | 2 | 2021 | 215776 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.02 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.02 | Why? |
| Adult | 2 | 2021 | 244371 | 0.02 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| France | 1 | 2021 | 12074 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.02 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.02 | Why? |
| Disease Models, Animal | 1 | 2021 | 10998 | 0.02 | Why? |
| Computational Biology | 1 | 2017 | 4514 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Protein Binding | 1 | 2017 | 11430 | 0.01 | Why? |
| Anticoagulants | 1 | 2021 | 9563 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.00 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
Mauvais-Jarvis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(219)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(126)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_